All Stories

  1. Cause and preventability of in-hospital mortality after PCI: A statewide root-cause analysis of 1,163 deaths
  2. Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan
  3. Trends and outcomes of non-primary PCI at sites without cardiac surgery on-site: The early Michigan experience
  4. Bivalirudin in radial PCI
  5. Reply to: Prepercutaneous coronary interventions statin therapy: Is it necessary?
  6. Preprocedural statin use in patients undergoing percutaneous coronary intervention
  7. Renal Complications in the Catheterization Laboratory
  8. A Practical Approach to Preventing Renal Complications in the Catheterization Laboratory
  9. Predicting Contrast-induced Renal Complications in the Catheterization Laboratory
  10. Daylight savings time and myocardial infarction
  11. Comparative Safety of Vascular Closure Devices
  12. The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction
  13. Peripheral Arterial Disease
  14. Differences in the outcome of patients undergoing percutaneous coronary interventions at teaching versus non-teaching hospitals
  15. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
  16. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention
  17. Non-Invasive Embolus Trap Using Histotripsy—An Acoustic Parameter Study
  18. Drug-Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Intervention
  19. Carotid Artery Stenting Versus Carotid Endarterectomy: Post CREST
  20. How A Regional Collaborative Of Hospitals And Physicians In Michigan Cut Costs And Improved The Quality Of Care
  21. Contrast agents
  22. Reply
  23. Resistance to Antiplatelet Drugs
  24. Rivaroxaban in acute coronary syndromes: too soon to know?
  25. Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: A meta-analysis
  26. Cardiogenic Shock Complicating Myocardial Infarction
  27. The human bovine arch—a common misnomer
  28. The ECG in acute coronary syndromes: new tricks from an old dog
  29. Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors
  30. Intravenous Platelet Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes
  31. Smokeless Tobacco and Cardiovascular Risk
  32. Preprocedural white blood cell count and death after percutaneous coronary intervention
  33. Calcium Channel Blockers and Benign Hypertension